Literature DB >> 13378061

Some clinical experiences with the arylsulfonylureas in the management of diabetes mellitus.

V ERK, H HAAR, T H MCGAVACK, W SEEGERS.   

Abstract

Entities:  

Keywords:  DIABETES MELLITUS/therapy; SULFANILAMIDE/related compounds; SULFONAMIDES/therapeutic use; UREA/related compounds

Mesh：

Substances：

Year:  1956        PMID： 13378061

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  4 in total

1.  Experience with glipasol (R. P. 2259)-an antidiabetic sulfonamide drug.

Authors:  T W DAVIS; R B KERR; A BOGOCH
Journal:  Can Med Assoc J       Date:  1959-07-15       Impact factor: 8.262

2.  The hypoglycaemic sulphonylureas.

Authors:  G WALKER
Journal:  Postgrad Med J       Date:  1957-05       Impact factor: 2.401

3.  Oral administration of orinase (tolbutamide); clinical observations of effect on nondiabetic and diabetic humans.

Authors:  T H LAMBERT; W F BETHARD; S PALMER; L S MONROE
Journal:  Calif Med       Date:  1958-02

4.  Effect of iodine administration on thyroid function in diabetic patients.

Authors:  G Robuschi; R Emanuele; L T Cavalli Sforza; L Arsenio; A Strata; A Gnudi; E Roti
Journal:  Acta Diabetol Lat       Date:  1984 Oct-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.